Do the tumors of patients with a history of cancer differ from those with no history?

  • Breast cancer patients with a prior cancer history
    • Some of the questions we are working on:
      • What are the differences at the molecular level between patients with and without a prior cancer?
      • What can we learn about these tumors be integrating multiple “omics” data?
      • Can we identify molecular alterations that are clinically relevant?